| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.31 | 9e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |